Insufficient scRNA-seq data for expression of YJEFN3 at single-cell level.
Insufficient scRNA-seq data for expression of YJEFN3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 6734.33 | 2587 / 2642 | 97% | 8.61 | 684 / 705 |
prostate | 99% | 3538.18 | 243 / 245 | 91% | 5.64 | 459 / 502 |
ovary | 97% | 1592.71 | 175 / 180 | 92% | 5.43 | 396 / 430 |
uterus | 95% | 1656.75 | 162 / 170 | 92% | 5.07 | 424 / 459 |
bladder | 100% | 1577.48 | 21 / 21 | 83% | 4.60 | 420 / 504 |
thymus | 100% | 2452.45 | 650 / 653 | 75% | 3.02 | 453 / 605 |
intestine | 99% | 1977.10 | 957 / 966 | 70% | 2.11 | 370 / 527 |
esophagus | 83% | 1453.91 | 1206 / 1445 | 83% | 3.04 | 151 / 183 |
kidney | 99% | 1428.74 | 88 / 89 | 66% | 2.94 | 594 / 901 |
lung | 82% | 908.70 | 475 / 578 | 72% | 2.96 | 831 / 1155 |
breast | 78% | 803.88 | 356 / 459 | 75% | 2.83 | 841 / 1118 |
pancreas | 59% | 567.15 | 194 / 328 | 88% | 3.12 | 156 / 178 |
skin | 69% | 691.71 | 1244 / 1809 | 74% | 4.50 | 349 / 472 |
stomach | 69% | 757.08 | 247 / 359 | 60% | 1.48 | 172 / 286 |
liver | 60% | 567.64 | 136 / 226 | 51% | 1.87 | 208 / 406 |
adrenal gland | 32% | 260.10 | 82 / 258 | 74% | 2.56 | 171 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 4.38 | 29 / 29 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.12 | 1 / 1 |
spleen | 97% | 1353.93 | 233 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 85% | 943.40 | 1137 / 1335 | 0% | 0 | 0 / 0 |
adipose | 80% | 819.11 | 959 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 76% | 2.85 | 34 / 45 |
heart | 67% | 717.42 | 577 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 56% | 6.98 | 45 / 80 |
muscle | 43% | 407.02 | 342 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 19% | 162.29 | 181 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008593 | Biological process | regulation of Notch signaling pathway |
GO_0010874 | Biological process | regulation of cholesterol efflux |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_0071425 | Biological process | hematopoietic stem cell proliferation |
GO_0031580 | Biological process | membrane raft distribution |
GO_0006869 | Biological process | lipid transport |
GO_0002040 | Biological process | sprouting angiogenesis |
GO_0052856 | Molecular function | NADHX epimerase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | YJEFN3 |
Protein name | YjeF N-terminal domain containing 3 FLJ44968 protein, isoform CRA_c (YJEFN3 protein) (cDNA FLJ44968 fis, clone BRAWH2016562) YjeF N-terminal domain-containing protein 3 (YjeF_N3) (hYjeF_N3) (ApoA-I-binding protein 2) |
Synonyms | AIBP2 FLJ44968 hCG_1641546 |
Description | FUNCTION: May accelerate cholesterol efflux from endothelial cells to high-density lipoprotein (HDL) and thereby regulates angiogenesis. May orchestrate hematopoietic stem and progenitor cell emergence from the hemogenic endothelium, a type of specialized endothelium manifesting hematopoietic potential. YJEFN3-mediated cholesterol efflux activates endothelial SREBF2, the master transcription factor for cholesterol biosynthesis, which in turn transactivates NOTCH and promotes hematopoietic stem and progenitor cell emergence (By similarity). May play a role in spermiogenesis and oogenesis . . |
Accessions | A0A087WUA6 ENST00000458210.7 ENST00000436027.9 [A6XGL0-2] Q6ZT45 ENST00000514277.6 [A6XGL0-1] A6XGL0 |